Escopo da BSI para o MDR – Regulation (EU) 2017/745 on medical devices http://ec.europa.eu/growth/tools-databases/nando/index.cfm?fuseaction=notification.pdf&dir_id=34&ntf_id=288798
Posts published in “UK”
Primeiro NB designado para o MDR – BSi UK http://ec.europa.eu/growth/tools-databases/nando/index.cfm?fuseaction=directive.notifiedbody&dir_id=34
Actions that providers and commissioners of health and social care services should take to prepare for, and manage, the risks of a no-deal exit scenario…
MHRA response to EU exit no-deal legislative proposals consultation
Further guidance note on the regulation of medicines, medical devices and clinical trials if there’s no Brexit deal
After loosing the CE Mark and the ANSM recall – MHRA statement on Allergan
MHRA – Field safety notices – 03 to 07 December 2018. As a reminder, as part of Post Market Surveillance (PMS), manufacturers should track field…
From the GOV.UK website – Some news on the preparation if the Brexit deal is a no-deal. Letter to the health and care sector: update…